We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
LYMPHOSEEK (Norgine Pty Ltd)
Product name
LYMPHOSEEK
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
197 working days (255)
Active ingredients
tilmanocept
Registration type
NCE/NBE
Indication
This medicinal product is for diagnostic use only
Radiolabelled LYMPHOSEEK is indicated for imaging and intraoperative detection of sentinel lymph nodes draining a primary tumour in adult patients with breast cancer, melanoma, or localised squamous cell carcinoma of the oral cavity. External imaging and intraoperative evaluation may be performed using a gamma detection device.